Multiple sclerosis (MS) is one of the most widespread ... While these are the most recent statistics available, advances in a disease-modifying therapy (DMT) for MS may actually slow down the ...

Multiple Sclerosis (MS) is a lifelong condition that affects the brain and spinal cord, disrupting communication between the ...

In basic terms, scientists simply don’t know what causes multiple sclerosis, or MS. Your genes ... Scientists are especially interested in statistics about twins because identical twins ...

Multiple Sclerosis (MS) may be considered a rare disease in India, but for the thousands living with its unpredictable symptoms and progressive nature, it is anything but rare. MS is a chronic, ...

Multiple sclerosis (MS) is the result of the immune ... MS to complete a genome-wide association study (GWAS), which uses statistics to carefully link genetic variants to particular traits.

Multiple sclerosis (MS) is the result of the immune system mistakenly ... 12,000 people with MS to complete a genome-wide association study (GWAS), which uses statistics to carefully link genetic ...

Multiple Sclerosis Companies are AstraZeneca, AB Science, Immunic, Bristol-Myers Squibb, HuniLife Biotechnology, Inc., Sanofi, TG Therapeutics, Atara Biotherapeutics ...

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of "More Stamina," a gamified mobile health (mHealth) app designed to help people with multiple sclerosis ...

Throughout the course of multiple sclerosis, gradually progressive neurologic ... Safety data were summarized with the use of descriptive statistics (see the Supplementary Appendix).